Relmada Therapeutics, Inc(NASDAQ:RLMD) 
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing drugs to treat central nervous system (CNS) diseases and other disorders in the United States. Its lead product candidate, d-Methadone, an oral agent, which is in Phase II clinical trial for the treatment of de...
Website: http://www.relmada.com
Founded: 2004
Full Time Employees: 6
CEO: Sergio Traversa
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-02-28 | 2013-11-30 | 2013-08-31 | 2013-05-31 | 2013-02-28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
operating expenses: | ||||||||||||||||||||||||||||||||||||||||||||||||||
research and development | 8,087,845 | 8,072,479 | 4,036,267 | 2,819,377 | 11,951,023 | 10,999,981 | 11,149,136 | 10,721,089 | 13,305,306 | 14,752,061 | 10,454,072 | 13,740,205 | 15,861,010 | 26,868,367 | 30,529,108 | 30,912,671 | 25,012,853 | 25,273,862 | 33,993,974 | 17,331,507 | 14,022,227 | 14,903,808 | 11,237,186 | 5,323,953 | 4,507,784 | 1,887,367 | 3,069,899 | 1,275,948 | 1,257,418 | 1,421,482 | 959,253 | 1,666,902 | 150,720 | 165,750 | 184,550 | 490,691 | 254,105 | 364,152 | 11,799,571 | -609,121 | -2,118,204 | -2,864,728 | -2,274,767 | -2,091,553 | -718,974 | |||||
general and administrative | 11,373,909 | 12,260,633 | 6,291,079 | 7,401,929 | 6,267,412 | 8,075,573 | 11,859,702 | 8,097,695 | 9,682,554 | 12,077,259 | 12,238,566 | 12,286,521 | 12,292,599 | 11,834,053 | 8,208,053 | 14,599,401 | 13,284,570 | 8,908,912 | 8,659,661 | 9,130,373 | 8,382,976 | 6,019,643 | 5,946,396 | 7,433,249 | 5,466,654 | 1,820,043 | 1,065,803 | 1,426,056 | 2,221,566 | 989,748 | 970,870 | 883,009 | 1,305,865 | 815,106 | 1,598,334 | 1,792,261 | 1,282,296 | 1,252,444 | 17,529,102 | -2,137,967 | -3,604,109 | -1,559,264 | -2,293,062 | -2,293,329 | -3,003,603 | 3,905 | 9,010 | 12,364 | 19,797 | 3,905 |
total operating expenses | 19,461,754 | 20,333,112 | 10,327,346 | 10,221,306 | 18,218,435 | 19,075,554 | 23,008,838 | 18,818,784 | 22,987,860 | 26,829,320 | 22,692,638 | 26,026,726 | 28,153,609 | 38,702,420 | 38,737,161 | 45,512,072 | 38,297,423 | 34,182,774 | 42,653,635 | 26,461,880 | 22,405,203 | 20,923,451 | 17,183,582 | 12,757,202 | 9,974,438 | 3,707,410 | 4,135,702 | 2,702,004 | 3,478,984 | 2,411,230 | 1,930,123 | 2,549,911 | 1,456,585 | 980,856 | 1,782,884 | 2,282,952 | 1,536,401 | 1,616,596 | 29,328,673 | -2,747,088 | -5,722,313 | -4,423,992 | -4,567,829 | -4,384,882 | -3,722,577 | 4,628 | 9,319 | 12,364 | 19,797 | 4,628 |
income from operations | -19,461,754 | -20,333,112 | -10,327,346 | -10,221,306 | -18,218,435 | -19,075,554 | -23,008,838 | -18,818,784 | -22,987,860 | -26,829,320 | -22,692,638 | -26,026,726 | -28,153,609 | -38,702,420 | -38,737,161 | -45,512,072 | -38,297,423 | -34,182,774 | -42,653,635 | -26,461,880 | -22,405,203 | -20,923,451 | -17,183,582 | -12,757,202 | -9,974,438 | -3,707,410 | -4,135,702 | -2,702,004 | -3,478,984 | -2,411,230 | -1,930,123 | -2,549,911 | -1,456,585 | -980,856 | -1,782,884 | -2,282,952 | -1,536,401 | -1,616,596 | -3,102,473 | -2,747,088 | -5,722,313 | -4,423,992 | -4,567,829 | -4,384,882 | -3,722,577 | -4,146 | -9,020 | -12,364 | -19,485 | -4,146 |
yoy | 6.82% | 6.59% | -55.12% | -45.69% | -20.75% | -28.90% | 1.39% | -27.69% | -18.35% | -30.68% | -41.42% | -42.81% | -26.49% | 13.22% | -9.18% | 71.99% | 70.93% | 63.37% | 148.22% | 107.43% | 124.63% | 464.37% | 315.49% | 372.14% | 186.71% | 53.76% | 114.27% | 5.96% | 138.85% | 145.83% | 8.26% | 11.69% | -5.19% | -39.33% | -42.53% | -16.90% | -73.15% | -63.46% | -32.08% | -37.35% | 53.72% | 106605.07% | 50541.12% | 35364.91% | 19004.83% | 0.00% | ||||
qoq | -4.29% | 96.89% | 1.04% | -43.90% | -4.49% | -17.09% | 22.27% | -18.14% | -14.32% | 18.23% | -12.81% | -7.55% | -27.26% | -0.09% | -14.89% | 18.84% | 12.04% | -19.86% | 61.19% | 18.11% | 7.08% | 21.76% | 34.70% | 27.90% | 169.04% | -10.36% | 53.06% | -22.33% | 44.28% | 24.93% | -24.31% | 75.06% | 48.50% | -44.98% | -21.90% | 48.59% | -4.96% | -47.89% | 12.94% | -51.99% | 29.35% | -3.15% | 4.17% | 17.79% | 89687.19% | -54.04% | -27.05% | -36.55% | 369.97% | |
other income: | ||||||||||||||||||||||||||||||||||||||||||||||||||
interest/investment income | 959,762 | 387,231 | 247,013 | 321,458 | 440,287 | 654,642 | 856,478 | 963,013 | 1,055,888 | 1,259,226 | 1,321,441 | 1,363,406 | 1,207,631 | 1,114,526 | 827,614 | 387,333 | 329,949 | 158,648 | 297,648 | 322,807 | 419,974 | 293,739.25 | 363,300 | 404,004 | 407,652 | |||||||||||||||||||||||||
realized gain on short-term investments | -9,867 | -107,924 | -81,438 | 47,203 | 62,952 | 40,844 | 147,835 | 133,114 | 53,133 | 24,502 | -123,590 | 12,810 | ||||||||||||||||||||||||||||||||||||||
unrealized gain on short-term investments | -540,097 | 186,045 | 70,275 | -13,797 | 155,731 | -277,068 | 278,555 | -45,465 | 50,713 | 3,750,905 | -579,147 | -639,634 | 1,291,110 | -974,283.75 | -947,512 | -231,683 | 86,745 | -289,281 | -151,706 | 3,946 | 1,221,947 | |||||||||||||||||||||||||||||
total other income | 409,798 | 354,864 | 658,970 | 1,050,662 | 1,159,734 | 723,772 | 1,832,033 | -1,448,360 | 37,916 | 13,110 | 15,939 | -3,650,326 | -968,863 | -1,419,809 | -651,973 | 29,235 | -830 | 149,267 | 301,458 | 505,572 | -23,985 | -214,918 | 887,308 | 3,261,651 | -3,542,686 | 2,104,868 | 9,840,259 | |||||||||||||||||||||||
net income | -19,051,956 | -19,867,760 | -10,091,496 | -9,866,442 | -17,559,465 | -18,657,136 | -21,725,970 | -17,768,122 | -21,828,126 | -25,165,158 | -22,002,058 | -25,302,954 | -26,321,576 | -37,944,365 | -39,418,707 | -39,934,968 | -39,745,783 | -34,378,493 | -42,606,191 | -26,551,944 | -22,215,181 | -20,762,130 | -16,902,507 | -11,118,441 | -10,673,316 | -3,669,494 | -4,122,592 | -2,686,065 | -7,129,310 | -3,380,093 | -3,349,932 | -3,201,884 | -1,427,350 | -981,686 | -1,633,617 | -1,981,494 | -1,030,829 | -1,640,581 | -3,317,391 | -1,859,780 | -2,460,662 | 6,042,436 | -2,462,961 | 5,455,377 | -29,838,448 | -4,146 | -9,020 | -12,364 | -19,485 | -4,146 |
yoy | 8.50% | 6.49% | -53.55% | -44.47% | -19.56% | -25.86% | -1.25% | -29.78% | -17.07% | -33.68% | -44.18% | -36.64% | -33.78% | 10.37% | -7.48% | 50.40% | 78.91% | 65.58% | 152.07% | 138.81% | 108.14% | 465.80% | 310.00% | 313.93% | 49.71% | 8.56% | 23.06% | -16.11% | 399.48% | 244.32% | 105.06% | 61.59% | 38.47% | -40.16% | -50.76% | 6.54% | -58.11% | -127.15% | 34.69% | -134.09% | -91.75% | -145841.34% | 27205.55% | -44223.08% | 153035.48% | 0.00% | ||||
qoq | -4.11% | 96.88% | 2.28% | -43.81% | -5.88% | -14.13% | 22.27% | -18.60% | -13.26% | 14.38% | -13.05% | -3.87% | -30.63% | -3.74% | -1.29% | 0.48% | 15.61% | -19.31% | 60.46% | 19.52% | 7.00% | 22.83% | 52.02% | 4.17% | 190.87% | -10.99% | 53.48% | -62.32% | 110.92% | 0.90% | 4.62% | 124.32% | 45.40% | -39.91% | -17.56% | 92.22% | -37.17% | -50.55% | 78.38% | -24.42% | -140.72% | -345.33% | -145.15% | -118.28% | 719592.43% | -54.04% | -27.05% | -36.55% | 369.97% | |
loss per common share – basic and diluted | -0.22 | -0.29 | -0.3 | -0.3 | -0.58 | -0.508 | -0.72 | -0.59 | -0.72 | -0.613 | -0.73 | -0.84 | -0.87 | -1.01 | -1.31 | -1.33 | -1.4 | -1.34 | -2.44 | -1.56 | -0.63 | -1.05 | -0.73 | -0.72 | -0.145 | -0.09 | -0.113 | -0.26 | ||||||||||||||||||||||
weighted-average number of common shares outstanding – basic and diluted | 86,596,873 | 39,479,694 | 33,191,622 | 33,191,622 | 30,408,890 | 30,163,751 | 30,174,202 | 30,174,202 | 30,132,170 | 30,099,203 | 30,099,203 | 30,099,203 | 30,099,203 | 29,628,664 | 30,063,735 | 29,935,895 | 28,392,601 | 17,552,738 | 17,478,477 | 17,054,646 | 16,572,672 | 15,594,228 | 16,044,670 | 15,323,051 | 14,738,230 | 9,761,188 | 25,247,075 | 30,037,971 | 25,583,922 | 12,549,870 | 12,545,342 | 12,547,620 | 12,547,176 | 12,532,840 | 12,074,244 | 11,598,952 | ||||||||||||||
other (expenses) income: | ||||||||||||||||||||||||||||||||||||||||||||||||||
total other income – net | 312,421.25 | 235,850 | 873,316 | 1,282,868 | 811,596.25 | 690,580 | 861,799.5 | -681,546 | ||||||||||||||||||||||||||||||||||||||||||
other income | 587.5 | 2,350 | 42,682 | 56,910 | 56,909 | 56,909 | 61,610 | 54,559 | ||||||||||||||||||||||||||||||||||||||||||
gain on settlement of fees | 6,351,606 | |||||||||||||||||||||||||||||||||||||||||||||||||
realized loss on short-term investments | -3,345,969 | -51,714 | -666,708 | -33,351 | -561,648 | -15,022 | -122,684 | -336,949 | -52,789 | 88,759 | -86,171 | -171,611 | ||||||||||||||||||||||||||||||||||||||
unrealized loss on short-term investments | -1,186,337 | -1,763,287 | -177,163 | -934,919 | ||||||||||||||||||||||||||||||||||||||||||||||
total other (expenses) income | 5,577,104 | -90,064 | 305,239.5 | 281,075 | 1,638,761 | -698,878 | ||||||||||||||||||||||||||||||||||||||||||||
total other income - net | 36,850.5 | 47,444 | ||||||||||||||||||||||||||||||||||||||||||||||||
total other income (expenses) | 190,022 | |||||||||||||||||||||||||||||||||||||||||||||||||
net loss per common share – basic and diluted | -1.34 | -0.38 | -0.27 | -0.08 | -0.73 | |||||||||||||||||||||||||||||||||||||||||||||
change in fair value of derivative liabilities | 263,907 | -318,541 | -789,443 | -254,862 | 341,106 | -5,702 | 103,577 | 244,075 | 449,041 | -80,043 | -278,424 | 831,971 | 3,261,980 | -3,543,975.75 | 2,102,565 | 9,836,252 | -26,114,720 | |||||||||||||||||||||||||||||||||
interest income | 37,916 | -193,537 | 15,939 | -650,322 | -176,615 | -397,111 | -311,871 | 2,522 | 1,896 | 778 | 843 | 1,233 | 2,428 | 5,105 | 2,117 | |||||||||||||||||||||||||||||||||||
loss on extinguishment of debt | -3,774,468 | |||||||||||||||||||||||||||||||||||||||||||||||||
interest expense | -139,765 | -851 | -1,172 | -431 | -125 | -1,098 | -3,268 | |||||||||||||||||||||||||||||||||||||||||||
loss per common share – basic | -0.28 | -0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||
loss per common share – diluted | -0.28 | -0.11 | ||||||||||||||||||||||||||||||||||||||||||||||||
net interest income | -189 | 473 | ||||||||||||||||||||||||||||||||||||||||||||||||
net income per common share - basic | -0.098 | -0.16 | -0.14 | 0.008 | -0.15 | -0.22 | ||||||||||||||||||||||||||||||||||||||||||||
net income per common share - diluted | -0.098 | -0.16 | -0.09 | -0.14 | 0.008 | -0.15 | -0.22 | |||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding: | ||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 12,035,912 | 12,035,912 | ||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 12,035,912 | 12,035,912 | ||||||||||||||||||||||||||||||||||||||||||||||||
net interest | -378 | |||||||||||||||||||||||||||||||||||||||||||||||||
net income per common share – basic | -0.09 | -0.14 | -0.05 | 0.11 | ||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of common stock outstanding - basic | 12,035,335 | 12,003,789 | ||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of common stock outstanding - diluted | 12,035,335 | 12,003,789 | ||||||||||||||||||||||||||||||||||||||||||||||||
net income per common share – diluted | -0.14 | -0.05 | 0.08 | |||||||||||||||||||||||||||||||||||||||||||||||
total other expenses | -26,115,871 | |||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average number of common shares outstanding - basic and diluted | 9,941,156 | 40,727,148 | ||||||||||||||||||||||||||||||||||||||||||||||||
revenues | 2,346 | 2,149 | 634 | 2,346 | ||||||||||||||||||||||||||||||||||||||||||||||
cost of goods sold | 1,864 | 1,850 | 322 | 1,864 | ||||||||||||||||||||||||||||||||||||||||||||||
gross margin | 482 | 299 | 312 | 482 | ||||||||||||||||||||||||||||||||||||||||||||||
yoy | 0.00% | |||||||||||||||||||||||||||||||||||||||||||||||||
qoq | 61.20% | -35.27% | ||||||||||||||||||||||||||||||||||||||||||||||||
operating expenses | ||||||||||||||||||||||||||||||||||||||||||||||||||
advertising and promotion | 723 | 309 | 723 | |||||||||||||||||||||||||||||||||||||||||||||||
loss on impairment of inventory | ||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted loss per common share | ||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted weighted-average number of common shares outstanding | 23,500,000 | 24,331,849 | 23,500,000 | 23,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted weighted average number of common shares outstanding | 23,500,000 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2014-02-28 | 2013-11-30 | 2013-08-31 | 2013-05-31 | 2013-02-28 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | ||||||||||||||||||||||||||||||||
current assets: | ||||||||||||||||||||||||||||||||
cash and cash equivalents | 9,776,400 | 3,496,540 | 1,384,484 | 1,353,351 | 1,149,706 | 3,857,026 | 1,483,789 | 2,086,260 | 1,335,018 | 4,091,568 | 6,698,599 | 14,469,354 | 28,894,360 | 5,395,905 | 42,524,369 | 37,260,866 | 44,934,376 | 44,443,439 | 11,449,294 | 4,669,345 | 3,804,042 | 2,495,397 | 7,544,728 | 13,824,258 | 12,226,487 | 7,849,873 | 9,216,554 | |||||
short-term investments | 224,186,743 | 89,509,710 | 12,502,040 | 19,266,190 | 25,911,326 | 41,052,356 | 52,633,938 | 68,351,069 | 82,277,687 | 92,232,292 | 99,568,502 | 104,059,737 | 103,547,634 | 142,926,781 | 141,627,805 | 174,694,211 | 175,715,526 | 167,466,167 | 76,637,802 | 104,399,140 | 98,899,732 | 114,595,525 | 115,593,750 | 120,263,581 | 102,690,508 | |||||||
prepaid expenses | 1,380,151 | 977,721 | 967,745 | 474,628 | 596,410 | 886,461 | 1,584,803 | 537,522 | 752,334 | 1,185,057 | 2,834,037 | 3,474,540 | 3,089,580 | 4,035,186 | 2,953,739 | 3,483,744 | 5,063,960 | 11,301,535 | 2,715,478 | 1,548,880 | 990,695 | 903,190 | 2,249,199 | 240,534 | 246,007 | 376,902 | 520,745 | |||||
total current assets | 235,343,294 | 93,983,971 | 14,854,269 | 21,094,169 | 27,657,442 | 45,795,843 | 55,702,530 | 70,974,851 | 84,365,039 | 97,508,917 | 109,101,138 | 122,003,631 | 135,531,574 | 152,870,304 | 187,105,913 | 215,737,247 | 225,779,316 | 223,297,518 | 90,887,166 | 110,700,210 | 103,775,602 | 118,073,569 | 125,465,492 | 134,404,581 | 115,245,164 | 8,298,356 | 9,984,381 | 8,750 | 10,900 | 18,459 | 3,033 | 10,194 |
other assets | 19,500 | 19,500 | 21,975 | 21,975 | 21,975 | 21,975 | 21,975 | 53,625 | 43,125 | 43,125 | 47,715 | 34,590 | 34,875 | 34,875 | 16,095 | 35,238 | 28,293 | 28,293 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | 25,000 | |||||
total assets | 235,362,794 | 94,003,471 | 14,876,244 | 21,116,144 | 27,679,417 | 45,817,818 | 55,724,505 | 71,028,476 | 84,408,164 | 97,552,042 | 109,148,853 | 122,038,221 | 135,566,449 | 152,905,179 | 187,122,008 | 215,772,485 | 225,807,609 | 223,325,811 | 90,934,441 | 110,769,300 | 103,866,508 | 118,186,204 | 125,599,441 | 134,559,451 | 115,420,716 | 8,514,149 | 10,219,733 | 10,000 | 12,300 | 20,009 | 4,733 | 10,194 |
liabilities and stockholders’ equity | ||||||||||||||||||||||||||||||||
current liabilities: | ||||||||||||||||||||||||||||||||
accounts payable | 5,731,401 | 1,568,944 | 1,453,102 | 1,361,911 | 1,265,010 | 4,130,563 | 2,345,541 | 4,174,568 | 5,189,101 | 3,506,009 | 2,856,752 | 4,853,616 | 4,421,965 | 5,261,936 | 10,425,841 | 7,539,686 | 10,670,149 | 11,192,502 | 12,708,546 | 10,455,922 | 8,082,796 | 8,346,475 | 728,633 | 965,169 | 1,102,815 | 1,266,548 | 924,359 | 41,155 | 40,331 | 33,666 | 25,751 | 12,002 |
accrued expenses | 7,160,233 | 4,861,583 | 3,736,496 | 3,772,636 | 3,966,411 | 6,160,827 | 5,741,220 | 5,362,280 | 7,172,732 | 8,688,791 | 5,565,466 | 5,848,850 | 5,675,292 | 7,206,941 | 10,351,312 | 11,381,468 | 4,739,328 | 3,868,423 | 5,538,804 | 3,460,821 | 4,636,584 | 4,256,983 | 2,660,824 | 1,360,933 | 1,158,368 | 1,014,390 | 1,317,855 | |||||
total current liabilities | 12,891,634 | 6,430,527 | 5,189,598 | 5,134,547 | 5,231,421 | 10,291,390 | 8,086,761 | 9,536,848 | 12,361,833 | 12,194,800 | 8,422,218 | 10,702,466 | 10,097,257 | 12,468,877 | 20,777,153 | 18,921,154 | 15,409,477 | 15,060,925 | 18,247,350 | 13,916,743 | 12,719,380 | 12,603,458 | 3,389,457 | 2,326,102 | 2,261,183 | 2,606,418 | 41,155 | 40,331 | 33,666 | 26,026 | 12,002 | |
stock appreciation rights | 3,738,583 | 1,060,931 | 221,107 | 32,116 | 7,505 | 4,467 | 12,562 | |||||||||||||||||||||||||
total liabilities | 16,630,217 | 7,491,458 | 5,410,705 | 5,166,663 | 5,238,926 | 10,295,857 | 8,099,323 | 12,361,833 | 12,194,800 | 10,097,257 | 12,468,877 | 15,409,477 | 15,060,925 | 12,603,458 | 2,536,863 | 2,606,418 | ||||||||||||||||
commitments and contingencies | ||||||||||||||||||||||||||||||||
stockholders’ equity: | ||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value... | ||||||||||||||||||||||||||||||||
class a convertible preferred stock, 0.001 par value... | ||||||||||||||||||||||||||||||||
common stock, 0.001 par value... | 104,890 | 73,333 | 33,191 | 33,191 | 33,191 | 30,174 | 30,174 | 30,174 | 30,174 | 30,099 | 30,099 | 30,099 | 30,099 | 30,099 | 28,642 | 30,025 | 29,403 | 27,740 | 17,502 | 17,469 | 16,748 | 16,333 | 16,189 | 15,852 | 14,941 | 9,937 | 38,978 | |||||
additional paid-in capital | 935,946,841 | 784,705,878 | 687,831,786 | 684,224,232 | 680,848,800 | 676,373,822 | 669,819,907 | 661,960,383 | 654,746,964 | 646,229,824 | 636,434,059 | 625,041,121 | 613,871,604 | 602,517,138 | 590,482,783 | 581,569,169 | 555,181,624 | 513,304,258 | 343,358,208 | 324,917,516 | 292,660,864 | 284,881,716 | 280,746,968 | 273,868,163 | 243,676,817 | 121,299,210 | 119,236,704 | 15,000 | 15,000 | 15,000 | ||
accumulated deficit | -717,319,154 | -698,267,198 | -678,399,438 | -668,307,942 | -658,441,500 | -640,882,035 | -622,224,899 | -600,498,929 | -582,730,807 | -560,902,681 | -535,737,523 | -513,735,465 | -488,432,511 | -462,110,935 | -424,166,570 | -384,747,863 | -344,812,895 | -305,067,112 | -270,688,619 | -228,082,428 | -201,530,484 | -179,315,303 | -158,553,173 | -141,650,666 | -130,532,225 | -115,331,861 | -111,662,367 | |||||
total stockholders’ equity | 218,732,577 | 86,512,013 | 9,465,539 | 15,949,481 | 22,440,491 | 35,521,961 | 47,625,182 | 61,491,628 | 72,046,331 | 85,357,242 | 100,726,635 | 111,335,755 | 125,469,192 | 140,436,302 | 166,344,855 | 196,851,331 | 210,398,132 | 208,264,886 | 72,687,091 | 96,852,557 | 91,147,128 | 105,582,746 | 122,209,984 | 132,233,349 | 113,159,533 | 5,977,286 | 7,613,315 | |||||
total liabilities and stockholders’ equity | 235,362,794 | 94,003,471 | 14,876,244 | 21,116,144 | 27,679,417 | 45,817,818 | 55,724,505 | 71,028,476 | 84,408,164 | 97,552,042 | 109,148,853 | 122,038,221 | 135,566,449 | 152,905,179 | 187,122,008 | 215,772,485 | 225,807,609 | 223,325,811 | 90,934,441 | 110,769,300 | 103,866,508 | 118,186,204 | 125,599,441 | 134,559,451 | 115,420,716 | 8,514,149 | 10,219,733 | |||||
other receivables | 512,432 | |||||||||||||||||||||||||||||||
lease payments receivable – short term | 42,234 | 65,454 | 86,377 | 84,592 | 82,845 | 81,133 | 79,457 | 77,815 | 76,208 | 74,633 | 70,102 | |||||||||||||||||||||
other current assets | 256,192 | |||||||||||||||||||||||||||||||
fixed assets, net of accumulated depreciation | 452 | 1,258 | 2,081 | 2,935 | 3,964 | 6,110 | 7,210 | |||||||||||||||||||||||||
lease payments receivable – long term | 22,275 | 44,090 | 65,454 | 86,377 | 106,868 | 126,935 | 146,588 | 203,142 | ||||||||||||||||||||||||
other receivable | 7,529 | 176,980 | ||||||||||||||||||||||||||||||
notes payable | 255,925 | 364,204 | ||||||||||||||||||||||||||||||
note payable | ||||||||||||||||||||||||||||||||
lease payments receivable – short-term | 71,581 | |||||||||||||||||||||||||||||||
lease payments receivable – long-term | 184,683 | |||||||||||||||||||||||||||||||
derivative liabilities | ||||||||||||||||||||||||||||||||
promissory notes payable, net of discount of 0 and 4,548,543 | ||||||||||||||||||||||||||||||||
stockholders’ equity (deficit) : | ||||||||||||||||||||||||||||||||
current assets | ||||||||||||||||||||||||||||||||
cash | 2,626 | 6,166 | 15,290 | 664 | 7,504 | |||||||||||||||||||||||||||
inventory | 6,124 | 4,734 | 3,169 | 2,369 | 2,690 | |||||||||||||||||||||||||||
property, plant and equipment, net of accumulated depreciation | 1,250 | |||||||||||||||||||||||||||||||
liabilities and stockholders' deficit | ||||||||||||||||||||||||||||||||
current liabilities | ||||||||||||||||||||||||||||||||
stockholders' deficit | ||||||||||||||||||||||||||||||||
preferred stock: 0.001 par value... | ||||||||||||||||||||||||||||||||
common stock: 0.001 par value... | 28,500 | 28,500 | 28,500 | 23,500 | 23,500 | |||||||||||||||||||||||||||
deficit accumulated during the development stage | -74,655 | -71,531 | -57,157 | -44,793 | -25,308 | |||||||||||||||||||||||||||
total stockholders' deficit | -31,155 | |||||||||||||||||||||||||||||||
total liabilities and stockholders' deficit | 10,000 | |||||||||||||||||||||||||||||||
property, plant and equipment | 1,400 | 1,550 | ||||||||||||||||||||||||||||||
liabilities and stockholders' equity | ||||||||||||||||||||||||||||||||
stockholders' equity | ||||||||||||||||||||||||||||||||
total stockholders' equity | -28,031 | -13,657 | -21,293 | -1,808 | ||||||||||||||||||||||||||||
total liabilities and stockholders' equity | 12,300 | 20,009 | 4,733 | 10,194 | ||||||||||||||||||||||||||||
other current asset | ||||||||||||||||||||||||||||||||
property and equipment | 1,700 | |||||||||||||||||||||||||||||||
sales tax payable | 275 |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-02-28 | 2013-11-30 | 2013-08-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities | |||||||||||||||||||||||||||||||||||||||||||||||||
net loss | -19,051,956 | -19,867,760 | -10,091,496 | -9,866,442 | -17,559,465 | -18,657,136 | -21,725,970 | -17,768,122 | -21,828,126 | -25,165,158 | -22,002,058 | -25,302,954 | -26,321,576 | -37,944,365 | -39,418,707 | -39,934,968 | -39,745,783 | -34,378,493 | -42,606,191 | -26,551,944 | -22,215,181 | -20,762,130 | -16,902,507 | -11,118,441 | -10,673,316 | -4,122,592 | -2,686,065 | -7,129,310 | -3,380,093 | -3,349,932 | -3,201,884 | -1,427,350 | -981,686 | 6,042,436 | -2,462,961 | 5,455,377 | -29,838,448 | -3,124 | -14,374 | -12,364 | |||||||||
adjustments to reconcile net loss to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
stock-based compensation | 956,186 | 2,371,179 | 3,607,554 | 3,448,453 | 4,477,995 | 6,726,402 | 7,949,125 | 7,213,419 | 8,295,468 | 9,894,228 | 11,392,938 | 11,169,517 | 11,354,466 | 11,625,929 | 8,343,139 | 12,295,016 | 11,930,681 | 18,360,846 | 8,013,970 | 8,268,376 | 5,851,284 | 3,190,739 | 5,244,658 | 7,302,513 | 5,039,362 | 757,716 | 403,459 | 394,693 | 263,044 | 152,800 | 152,826 | 162,265 | 134,038 | 68,870 | 291,869 | 108,559 | 131,960 | 172,064 | 154,819 | 276,543 | 287,710 | 283,504 | 196,876 | 243,810 | 198,276 | 157,990 | |||
stock appreciation rights compensation | 2,677,652 | 24,611 | 3,038 | -8,095 | |||||||||||||||||||||||||||||||||||||||||||||
issuance of restricted common stock | |||||||||||||||||||||||||||||||||||||||||||||||||
realized loss on short-term investments | 9,867 | -40,844 | -147,835 | -133,114 | -53,133 | 3,345,969 | 51,714 | 0 | 666,708 | 33,351 | 561,651 | -24,502 | 15,022 | 122,684 | 336,949 | 123,590 | 52,789 | -88,759 | 86,171 | -12,810 | 171,611 | ||||||||||||||||||||||||||||
unrealized loss on short-term investments | 540,097 | -278,555 | -3,750,905 | 579,147 | 639,634 | -1,291,110 | 323,120 | 947,511 | 1,186,337 | 1,763,287 | 231,683 | -86,745 | 289,281 | 177,163 | 934,919 | ||||||||||||||||||||||||||||||||||
change in operating assets and liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses | -402,430 | 290,051 | 432,723 | 945,606 | 6,237,575 | -1,166,598 | -558,185 | -87,505 | -2,008,665 | 5,474 | 177,855 | 143,843 | 329,872 | -226,727 | 115,983 | 103,112 | 479,338 | ||||||||||||||||||||||||||||||||
accounts payable | 1,762,457 | 115,842 | 91,191 | 96,901 | -2,865,553 | 1,785,022 | -1,829,027 | -1,014,533 | 1,683,092 | 649,257 | -1,996,864 | 431,651 | -839,971 | 1,187,701 | -3,465,451 | 3,221,143 | -522,353 | -1,516,044 | 2,252,624 | 2,373,126 | -263,679 | 7,617,842 | -236,536 | -137,647 | 580,153 | 342,189 | -155,751 | 721,220 | -660,467 | 253,918 | -326,139 | 805,526 | -89,485 | -232,510 | 194,127 | 28,196 | -364,484 | -587,992 | 515,551 | -901,928 | 496,091 | 314,712 | 444,914 | -579,583 | 345,221 | -121,365 | 824 | 6,665 | 7,749 |
accrued expenses | -1,559,361 | 1,125,087 | -36,140 | -193,775 | -2,194,416 | 419,607 | 378,940 | -1,810,452 | -1,516,059 | 3,123,325 | -283,384 | 173,558 | -1,531,649 | -3,144,371 | -1,030,156 | 6,642,140 | 870,905 | -1,670,381 | 2,077,983 | -1,175,763 | 379,601 | 1,596,159 | 1,299,891 | 202,565 | 333,432 | -303,465 | 296,905 | -764,007 | 1,341,666 | 306,706 | 200,871 | -35,513 | 92,525 | -42,251 | -231,201 | 113,962 | 67,594 | -229,967 | -410,840 | -516,983 | 948,145 | 132,264 | -16,223 | -123,194 | -357,813 | 497,474 | |||
net cash from operating activities | -15,067,488 | -14,596,223 | -6,721,856 | -6,401,876 | -18,067,033 | -8,799,634 | -16,656,391 | -13,263,025 | -13,036,748 | -10,249,714 | -11,631,129 | -13,273,269 | -16,505,094 | -35,882,900 | -26,862,833 | -21,626,141 | -19,429,743 | -37,660,164 | -20,916,341 | -17,211,415 | -16,085,475 | -6,928,762 | -12,501,620 | -4,953,656 | -3,424,763 | -2,534,151 | -3,667,080 | -2,011,929 | -3,147,862 | -1,670,983 | -2,266,173 | -1,625,243 | -1,131,614 | -979,048 | -1,016,311 | -1,855,008 | -1,450,529 | -2,144,487 | -2,825,510 | -3,627,236 | -4,488,824 | -4,432,292 | -4,983,517 | -2,322,095 | -3,540 | -9,124 | -5,374 | ||
capital expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
free cash flows | -15,067,488 | -14,596,223 | -6,721,856 | -6,401,876 | -18,067,033 | -8,799,634 | -16,656,391 | -13,263,025 | -13,036,748 | -10,249,714 | -11,631,129 | -13,273,269 | -16,505,094 | -35,882,900 | -26,862,833 | -21,626,141 | -19,429,743 | -37,660,164 | -20,916,341 | -17,211,415 | -16,085,475 | -6,928,762 | -12,501,620 | -4,953,656 | -3,424,763 | -2,534,151 | -3,667,080 | -2,011,929 | -3,147,862 | -1,670,983 | -2,266,173 | -1,625,243 | -1,131,614 | -979,048 | -1,016,311 | -1,855,008 | -1,450,529 | -2,144,487 | -2,825,510 | -3,627,236 | -4,488,824 | -4,432,292 | -4,983,517 | -2,322,095 | -3,540 | -5,374 | |||
cash flows from investing activities | |||||||||||||||||||||||||||||||||||||||||||||||||
purchase of short-term investments | -149,517,480 | -82,785,269 | -233,932 | -321,459 | -487,916 | -654,642 | -3,111,674 | -1,299,379 | -7,013,933 | -33,311,569 | -11,574,131 | -10,810,545 | -34,767,287 | -8,300,590 | -5,580,748 | -7,496,468 | -25,915,957 | -140,505,136 | -25,604,080 | -36,208,924 | -20,663,535 | -26,399,016 | -25,133,545 | -37,230,631 | |||||||||||||||||||||||||
sale of short-term investments | 14,290,483 | 5,855,719 | 6,986,921 | 7,000,001 | 15,847,629 | 12,000,000 | 19,255,195 | 15,313,646 | 17,072,384 | 41,052,715 | 15,434,505 | 9,658,808 | 74,770,836 | 6,645,143 | 37,137,992 | 7,355,948 | 15,888,289 | 49,322,404 | 53,115,214 | 30,296,645 | 36,129,376 | 30,986,622 | 8,795,228 | 13,598,416 | |||||||||||||||||||||||||
net cash from investing activities | -135,226,997 | -76,929,550 | 6,752,989 | 6,678,542 | 15,359,713 | 11,345,358 | 16,143,521 | 14,014,267 | 10,058,451 | 7,741,146 | 3,860,374 | -1,151,737 | 40,003,549 | -1,655,447 | 31,557,244 | -140,520 | -10,027,668 | -91,182,732 | 935,278 | 4,587,606 | -16,338,317 | -23,632,215 | -9,800 | 0 | 0 | -2,591 | -2,202 | -20,227 | -2,434 | -24,827 | -23,043 | -63,108 | -3,870 | -2,286 | -6,500 | -10,670 | 0 | ||||||||||||
cash flows from financing activities | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock | 159,999,996 | 13,145,057 | 29,583,542 | 825,749 | |||||||||||||||||||||||||||||||||||||||||||||
payment of fees for issuance of common stock | -3,360,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
atm fees | -65,651 | -89,601 | 0 | -25,000 | |||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities | 156,574,345 | 93,637,829 | 0 | -172,487 | -89,601 | 0 | 221,747 | 409,883 | 569,092 | 14,093,151 | 29,948,348 | 161,837,041 | 185,156 | 23,988,997 | 1,928,279 | 944,153 | 1,634,484 | 22,889,744 | 3,004,946 | 1,167,470 | 10,829,781 | 1,639,031 | 4,687,119 | 319,534 | 257,290 | -56,655 | 2,386,571 | 3,955,694 | -27,583 | -82,450 | -54,403 | -109,234 | 0 | -88,533 | -87,915 | -87,304 | 6,250 | -28,089 | 9,018,267 | 4,159,235 | |||||||||
net increase in cash and cash equivalents | 6,279,860 | -602,471 | 751,242 | -2,756,550 | -7,770,755 | -14,425,006 | 23,498,455 | -37,128,464 | 5,263,503 | -7,673,510 | 490,937 | 32,994,145 | 6,779,949 | 865,303 | 1,308,645 | -5,049,331 | -6,279,530 | 7,162,701 | -372,898 | 1,539,257 | -1,351,449 | -2,018,683 | -1,681,898 | 1,254,957 | 2,974,055 | -3,778,877 | -4,462,667 | 4,028,250 | 1,826,470 | ||||||||||||||||||||
cash and cash equivalents at beginning of the period | 3,496,540 | 0 | 0 | 3,857,026 | 0 | 0 | 4,091,568 | 0 | 0 | 5,395,905 | 0 | 0 | 0 | 44,443,439 | 0 | 0 | 0 | 2,495,397 | 0 | 0 | 0 | 36,278,519 | 9,216,554 | 0 | 0 | 2,238,943 | 0 | 0 | 1,710,512 | 0 | 0 | 8,500,207 | 0 | 0 | 22,469,960 | 0 | 0 | 25,564,351 | |||||||||||
cash and cash equivalents at end of the period | 9,776,400 | 31,133 | 203,645 | 1,149,706 | -602,471 | 751,242 | 1,335,018 | -7,770,755 | -14,425,006 | 28,894,360 | -37,128,464 | 5,263,503 | -7,673,510 | 44,934,376 | 32,994,145 | 6,779,949 | 865,303 | 3,804,042 | -5,049,331 | -6,279,530 | 1,597,771 | 12,226,487 | 7,849,873 | -372,898 | 1,539,257 | 887,494 | -1,681,898 | 1,254,957 | 4,684,567 | -1,957,685 | -1,507,366 | 6,221,659 | -3,778,877 | -4,037,800 | 19,165,437 | -4,462,667 | 4,028,250 | 27,390,821 | |||||||||||
non-cash investing and financing activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
cashless exercise of warrants for common stock | -2,082 | 7 | 2 | 34 | |||||||||||||||||||||||||||||||||||||||||||||
fees for issuance of common stock included in accounts payable | 2,400,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
fees for issuance of common stock included in accrued expenses | 3,858,011 | ||||||||||||||||||||||||||||||||||||||||||||||||
unrealized gain on short-term investments | -186,045 | -155,731 | -50,713 | 151,706 | -3,946 | ||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other assets | -7,500 | -493,119 | 698,342 | -1,015,631 | 1,653,570 | 627,378 | -1,100,227 | 549,148 | -269,831 | 50,311 | 101,494 | 355,871 | 601,935 | -11,059 | |||||||||||||||||||||||||||||||||||
payment of atm fees | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from options exercised for common stock | 0 | 0 | 0 | 246,747 | 0 | 286,176 | 352,744 | 64,800 | 99,004 | 52,156 | 49,498 | 467,773 | 98,996 | 105,875 | 457,623 | 73,020 | |||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | 2,112,056 | -2,707,320 | -24,052,032 | -1,366,681 | -1,046,096 | -1,957,685 | -1,507,366 | -2,278,548 | |||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of the year | |||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of the year | |||||||||||||||||||||||||||||||||||||||||||||||||
realized gain on short-term investments | -62,952 | ||||||||||||||||||||||||||||||||||||||||||||||||
fair value changes on stock appreciation rights | |||||||||||||||||||||||||||||||||||||||||||||||||
atm expenses | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosure of cash flow information: | |||||||||||||||||||||||||||||||||||||||||||||||||
cash paid during the period for: | |||||||||||||||||||||||||||||||||||||||||||||||||
interest | 1,461 | -1,461 | 2,415 | 2,535 | 2,644 | ||||||||||||||||||||||||||||||||||||||||||||
income tax | |||||||||||||||||||||||||||||||||||||||||||||||||
realized (gain) on short-term investments | |||||||||||||||||||||||||||||||||||||||||||||||||
unrealized (gain) on short-term investments | |||||||||||||||||||||||||||||||||||||||||||||||||
other receivable | 0 | -7,529 | 176,980 | -176,980 | 0 | 0 | 7,617 | -7,617 | 0 | 150,617 | 81,980 | -2,350 | |||||||||||||||||||||||||||||||||||||
other receivables | 0 | 512,432 | |||||||||||||||||||||||||||||||||||||||||||||||
gain on settlement | |||||||||||||||||||||||||||||||||||||||||||||||||
lease payment receivable | 0 | 42,234 | 23,220 | 20,923 | 20,490 | 20,068 | 19,652 | 19,247 | 18,849 | 18,460 | 18,078 | 17,704 | 16,980 | 16,631 | 16,285 | 15,950 | 15,620 | 14,982 | 14,672 | 14,368 | |||||||||||||||||||||||||||||
payment of fees for warrants issued for common stock | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from warrants exercised for common stock | 36,251 | 332,916 | 595,350 | 300,006 | 511,092 | 175,014 | 481,449 | 1,460,506 | 870,110 | 1,567,030 | 2,577,103 | 3,042,173 | |||||||||||||||||||||||||||||||||||||
proceeds from short swing profit | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock – net | |||||||||||||||||||||||||||||||||||||||||||||||||
share exchange for pre-funded warrants | |||||||||||||||||||||||||||||||||||||||||||||||||
gain on settlement of fees | |||||||||||||||||||||||||||||||||||||||||||||||||
depreciation expense | 0 | 0 | 452 | 806 | 823 | 854 | 1,029 | 1,046 | 1,100 | 1,088 | 1,075 | 1,302 | 1,405 | 929 | 568 | 582 | 548 | 18,259 | 23,268 | 23,581 | 20,163 | 21,341 | 27,570 | 2,955 | 2,953 | 3,307 | 2,448 | -93 | 3,594 | ||||||||||||||||||||
income taxes | |||||||||||||||||||||||||||||||||||||||||||||||||
warrants issued for license agreement | |||||||||||||||||||||||||||||||||||||||||||||||||
other current assets | |||||||||||||||||||||||||||||||||||||||||||||||||
principal payments of notes payable | 0 | 0 | -110,247 | -108,279 | -85,969 | -85,466 | -84,966 | -82,506 | |||||||||||||||||||||||||||||||||||||||||
cashless exercise of options for common stock | |||||||||||||||||||||||||||||||||||||||||||||||||
net cash from (used) in investing activities | -5,912,279 | 15,465,841 | |||||||||||||||||||||||||||||||||||||||||||||||
amortization of deferred financing costs | 1 | 0 | 124,647 | 536,520 | 2,819 | ||||||||||||||||||||||||||||||||||||||||||||
change in fair value of derivative liabilities | 0 | -2 | -263,905 | 318,541 | 789,443 | 254,862 | -341,106 | 5,702 | -103,577 | -244,075 | -449,041 | 80,043 | 278,424 | -831,971 | -3,261,980 | -9,293,339 | -2,102,565 | -9,836,252 | 26,114,720 | ||||||||||||||||||||||||||||||
fair value of shares relinquished | |||||||||||||||||||||||||||||||||||||||||||||||||
loss on promissory note extinguishment | 0 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||
purchase of investments | |||||||||||||||||||||||||||||||||||||||||||||||||
sale of investments | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock, net of fees | |||||||||||||||||||||||||||||||||||||||||||||||||
principal payment of notes payable | |||||||||||||||||||||||||||||||||||||||||||||||||
fair value of shares relinquished in litigation | 0 | ||||||||||||||||||||||||||||||||||||||||||||||||
other assets | -25,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of common stock - net | |||||||||||||||||||||||||||||||||||||||||||||||||
notes payable issued in connection with directors and officers insurance policies | |||||||||||||||||||||||||||||||||||||||||||||||||
net income | -3,669,494 | -1,981,494 | -1,030,829 | -1,640,581 | -1,859,780 | -2,460,662 | 4,663,142 | ||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net income to net cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
warrants exercised for common stock | 450,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
units funds received | 404,500 | ||||||||||||||||||||||||||||||||||||||||||||||||
balances at july 1, 2019 | 9,744,643 | ||||||||||||||||||||||||||||||||||||||||||||||||
purchase of common stock | 117,965 | ||||||||||||||||||||||||||||||||||||||||||||||||
warrants exercised | 75,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
balances at september 30, 2019 | 9,937,608 | ||||||||||||||||||||||||||||||||||||||||||||||||
purchase of fixed assets | -9,800 | 0 | 0 | -2,591 | -2,202 | -20,227 | -2,434 | -24,827 | -23,043 | -63,108 | -474,795 | -1,310 | -3,870 | -2,286 | -6,500 | -10,670 | |||||||||||||||||||||||||||||||||
proceeds from promissory notes and warrants, net of fees | 0 | 26,700 | 2,469,500 | 4,038,200 | |||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equity units, net of fees | |||||||||||||||||||||||||||||||||||||||||||||||||
payment on notes payable | |||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from sale of units | 1,725,000 | ||||||||||||||||||||||||||||||||||||||||||||||||
loss on sales-type lease of fixed assets | |||||||||||||||||||||||||||||||||||||||||||||||||
gain on lease assignment | |||||||||||||||||||||||||||||||||||||||||||||||||
amortization of debt discount | 293,422 | ||||||||||||||||||||||||||||||||||||||||||||||||
other long-term liabilities | -6,178 | ||||||||||||||||||||||||||||||||||||||||||||||||
principal payments of note payable | -83,355 | -82,450 | -54,403 | -109,234 | -88,533 | -87,915 | -87,304 | -38,089 | -107,096 | -148,441 | |||||||||||||||||||||||||||||||||||||||
deferred rent liability | |||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses and other current assets | |||||||||||||||||||||||||||||||||||||||||||||||||
long-term liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||
common stock issued for services | 0 | 23,664 | 101,950 | 78,920 | 70,416 | 110,415 | 124,580 | 874,999 | |||||||||||||||||||||||||||||||||||||||||
prepaid expenses, other current assets and other assets | |||||||||||||||||||||||||||||||||||||||||||||||||
non-cash investing and financing transactions: | |||||||||||||||||||||||||||||||||||||||||||||||||
conversion of class a convertible preferred stock to common stock | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from exercise of a warrants, net of fees | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from warrant exercises from consultants and series a preferred stock warrant holder | |||||||||||||||||||||||||||||||||||||||||||||||||
payments on notes payable | |||||||||||||||||||||||||||||||||||||||||||||||||
net proceeds from the exercise of warrants | 10,000 | 9,125,363 | 4,307,676 | ||||||||||||||||||||||||||||||||||||||||||||||
net cash used in operating activities | -3,215,909 | ||||||||||||||||||||||||||||||||||||||||||||||||
net cash used in investing activities | -1,310 | ||||||||||||||||||||||||||||||||||||||||||||||||
net (decrease) increase in cash and cash equivalents | -3,304,523 | ||||||||||||||||||||||||||||||||||||||||||||||||
loss on change in fair value of derivative liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of series a preferred stock and warrants | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of common stock and warrants, net of fees | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of common and class a series a preferred stock, pursuant to share exchange | |||||||||||||||||||||||||||||||||||||||||||||||||
payment of notes payable | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from subordinated promissory notes payable, net of financing costs | |||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash | -3,540 | -9,124 | 14,626 | ||||||||||||||||||||||||||||||||||||||||||||||
cash at beginning of the period | |||||||||||||||||||||||||||||||||||||||||||||||||
cash at end of the period | |||||||||||||||||||||||||||||||||||||||||||||||||
payment of deferred offering costs | |||||||||||||||||||||||||||||||||||||||||||||||||
operating activities | |||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net loss to cash from operating activities: | |||||||||||||||||||||||||||||||||||||||||||||||||
depreciation | 150 | 150 | 150 | ||||||||||||||||||||||||||||||||||||||||||||||
inventory | -1,390 | -1,565 | -800 | ||||||||||||||||||||||||||||||||||||||||||||||
investing activities | |||||||||||||||||||||||||||||||||||||||||||||||||
purchase of property, plant and equipment | |||||||||||||||||||||||||||||||||||||||||||||||||
financing activities | |||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the issuance of common stock | |||||||||||||||||||||||||||||||||||||||||||||||||
cash at beginning of period | 0 | 15,290 | 0 | ||||||||||||||||||||||||||||||||||||||||||||||
cash at end of period | -3,540 | 6,166 | 14,626 | ||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of cash flow information | |||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for: | |||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of | |||||||||||||||||||||||||||||||||||||||||||||||||
cash flow information | |||||||||||||||||||||||||||||||||||||||||||||||||
sales tax payable | -109 | ||||||||||||||||||||||||||||||||||||||||||||||||
purchase of property and equipment |